Direct Assay of miR-223, miR-145, and miR-16 by a Novel Method of Mimic PCR in Serum of Breast Cancer Patients
The role of microRNAs (miRs) is shown as a biomarker whose expression level changes have been associated with cancer development and progression. Circulating miRNAs have been postulated as biomarkers for breast cancer. Detection and diagnosis of miRNA markers could provide an improved and sensitive...
Ausführliche Beschreibung
Autor*in: |
Elham Ghazizadeh [verfasserIn] Faranak Hadi [verfasserIn] Maryam Zare [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2016 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Journal of Genetic Resources - University of Mazandaran, 2021, 2(2016), 2, Seite 98-108 |
---|---|
Übergeordnetes Werk: |
volume:2 ; year:2016 ; number:2 ; pages:98-108 |
Links: |
Link aufrufen |
---|
DOI / URN: |
10.22080/jgr.2017.12953.1068 |
---|
Katalog-ID: |
DOAJ055813569 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ055813569 | ||
003 | DE-627 | ||
005 | 20230308193632.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230227s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.22080/jgr.2017.12953.1068 |2 doi | |
035 | |a (DE-627)DOAJ055813569 | ||
035 | |a (DE-599)DOAJ0dc864074bf64c42993fe5f0f7897391 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a QH426-470 | |
100 | 0 | |a Elham Ghazizadeh |e verfasserin |4 aut | |
245 | 1 | 0 | |a Direct Assay of miR-223, miR-145, and miR-16 by a Novel Method of Mimic PCR in Serum of Breast Cancer Patients |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a The role of microRNAs (miRs) is shown as a biomarker whose expression level changes have been associated with cancer development and progression. Circulating miRNAs have been postulated as biomarkers for breast cancer. Detection and diagnosis of miRNA markers could provide an improved and sensitive method in the clinical application. In this study, we applied and improved the effective approach by coupling a deoxyuridine-incorporated RT oligonucleotide with a secondary structure and a mimic PCR for assessment and direct detection of circulating miRs in serum. We designed mut miR-16, mut miR-145, and mut miR-223 as mimic miRs. These mimic miRs were used in RT-PCR for detection and quantification assay. As normalization of these mut miRs was performed with themselves, our mimic construct with 80 bp of these miRs shows the best normalization for this method in blood samples. This assay was tested in serum from 15 patients with different stages of breast cancer and 10 healthy female donors. According to our results, using a combination of miR-16 and miR-145 could represent as one of the best biomarker (p | ||
650 | 4 | |a biomarker | |
650 | 4 | |a micro rna | |
650 | 4 | |a mimic pcr | |
650 | 4 | |a breast cancer | |
653 | 0 | |a Genetics | |
700 | 0 | |a Faranak Hadi |e verfasserin |4 aut | |
700 | 0 | |a Maryam Zare |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Journal of Genetic Resources |d University of Mazandaran, 2021 |g 2(2016), 2, Seite 98-108 |w (DE-627)1767903766 |x 25882589 |7 nnns |
773 | 1 | 8 | |g volume:2 |g year:2016 |g number:2 |g pages:98-108 |
856 | 4 | 0 | |u https://doi.org/10.22080/jgr.2017.12953.1068 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/0dc864074bf64c42993fe5f0f7897391 |z kostenfrei |
856 | 4 | 0 | |u http://sc.journals.umz.ac.ir/article_1659_caa74ab91b02ca38fd6cc5a6298035ba.pdf |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2423-4257 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2588-2589 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 2 |j 2016 |e 2 |h 98-108 |
author_variant |
e g eg f h fh m z mz |
---|---|
matchkey_str |
article:25882589:2016----::ietsaomr2mr4adi1baoemtoommccisr |
hierarchy_sort_str |
2016 |
callnumber-subject-code |
QH |
publishDate |
2016 |
allfields |
10.22080/jgr.2017.12953.1068 doi (DE-627)DOAJ055813569 (DE-599)DOAJ0dc864074bf64c42993fe5f0f7897391 DE-627 ger DE-627 rakwb eng QH426-470 Elham Ghazizadeh verfasserin aut Direct Assay of miR-223, miR-145, and miR-16 by a Novel Method of Mimic PCR in Serum of Breast Cancer Patients 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The role of microRNAs (miRs) is shown as a biomarker whose expression level changes have been associated with cancer development and progression. Circulating miRNAs have been postulated as biomarkers for breast cancer. Detection and diagnosis of miRNA markers could provide an improved and sensitive method in the clinical application. In this study, we applied and improved the effective approach by coupling a deoxyuridine-incorporated RT oligonucleotide with a secondary structure and a mimic PCR for assessment and direct detection of circulating miRs in serum. We designed mut miR-16, mut miR-145, and mut miR-223 as mimic miRs. These mimic miRs were used in RT-PCR for detection and quantification assay. As normalization of these mut miRs was performed with themselves, our mimic construct with 80 bp of these miRs shows the best normalization for this method in blood samples. This assay was tested in serum from 15 patients with different stages of breast cancer and 10 healthy female donors. According to our results, using a combination of miR-16 and miR-145 could represent as one of the best biomarker (p biomarker micro rna mimic pcr breast cancer Genetics Faranak Hadi verfasserin aut Maryam Zare verfasserin aut In Journal of Genetic Resources University of Mazandaran, 2021 2(2016), 2, Seite 98-108 (DE-627)1767903766 25882589 nnns volume:2 year:2016 number:2 pages:98-108 https://doi.org/10.22080/jgr.2017.12953.1068 kostenfrei https://doaj.org/article/0dc864074bf64c42993fe5f0f7897391 kostenfrei http://sc.journals.umz.ac.ir/article_1659_caa74ab91b02ca38fd6cc5a6298035ba.pdf kostenfrei https://doaj.org/toc/2423-4257 Journal toc kostenfrei https://doaj.org/toc/2588-2589 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2 2016 2 98-108 |
spelling |
10.22080/jgr.2017.12953.1068 doi (DE-627)DOAJ055813569 (DE-599)DOAJ0dc864074bf64c42993fe5f0f7897391 DE-627 ger DE-627 rakwb eng QH426-470 Elham Ghazizadeh verfasserin aut Direct Assay of miR-223, miR-145, and miR-16 by a Novel Method of Mimic PCR in Serum of Breast Cancer Patients 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The role of microRNAs (miRs) is shown as a biomarker whose expression level changes have been associated with cancer development and progression. Circulating miRNAs have been postulated as biomarkers for breast cancer. Detection and diagnosis of miRNA markers could provide an improved and sensitive method in the clinical application. In this study, we applied and improved the effective approach by coupling a deoxyuridine-incorporated RT oligonucleotide with a secondary structure and a mimic PCR for assessment and direct detection of circulating miRs in serum. We designed mut miR-16, mut miR-145, and mut miR-223 as mimic miRs. These mimic miRs were used in RT-PCR for detection and quantification assay. As normalization of these mut miRs was performed with themselves, our mimic construct with 80 bp of these miRs shows the best normalization for this method in blood samples. This assay was tested in serum from 15 patients with different stages of breast cancer and 10 healthy female donors. According to our results, using a combination of miR-16 and miR-145 could represent as one of the best biomarker (p biomarker micro rna mimic pcr breast cancer Genetics Faranak Hadi verfasserin aut Maryam Zare verfasserin aut In Journal of Genetic Resources University of Mazandaran, 2021 2(2016), 2, Seite 98-108 (DE-627)1767903766 25882589 nnns volume:2 year:2016 number:2 pages:98-108 https://doi.org/10.22080/jgr.2017.12953.1068 kostenfrei https://doaj.org/article/0dc864074bf64c42993fe5f0f7897391 kostenfrei http://sc.journals.umz.ac.ir/article_1659_caa74ab91b02ca38fd6cc5a6298035ba.pdf kostenfrei https://doaj.org/toc/2423-4257 Journal toc kostenfrei https://doaj.org/toc/2588-2589 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2 2016 2 98-108 |
allfields_unstemmed |
10.22080/jgr.2017.12953.1068 doi (DE-627)DOAJ055813569 (DE-599)DOAJ0dc864074bf64c42993fe5f0f7897391 DE-627 ger DE-627 rakwb eng QH426-470 Elham Ghazizadeh verfasserin aut Direct Assay of miR-223, miR-145, and miR-16 by a Novel Method of Mimic PCR in Serum of Breast Cancer Patients 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The role of microRNAs (miRs) is shown as a biomarker whose expression level changes have been associated with cancer development and progression. Circulating miRNAs have been postulated as biomarkers for breast cancer. Detection and diagnosis of miRNA markers could provide an improved and sensitive method in the clinical application. In this study, we applied and improved the effective approach by coupling a deoxyuridine-incorporated RT oligonucleotide with a secondary structure and a mimic PCR for assessment and direct detection of circulating miRs in serum. We designed mut miR-16, mut miR-145, and mut miR-223 as mimic miRs. These mimic miRs were used in RT-PCR for detection and quantification assay. As normalization of these mut miRs was performed with themselves, our mimic construct with 80 bp of these miRs shows the best normalization for this method in blood samples. This assay was tested in serum from 15 patients with different stages of breast cancer and 10 healthy female donors. According to our results, using a combination of miR-16 and miR-145 could represent as one of the best biomarker (p biomarker micro rna mimic pcr breast cancer Genetics Faranak Hadi verfasserin aut Maryam Zare verfasserin aut In Journal of Genetic Resources University of Mazandaran, 2021 2(2016), 2, Seite 98-108 (DE-627)1767903766 25882589 nnns volume:2 year:2016 number:2 pages:98-108 https://doi.org/10.22080/jgr.2017.12953.1068 kostenfrei https://doaj.org/article/0dc864074bf64c42993fe5f0f7897391 kostenfrei http://sc.journals.umz.ac.ir/article_1659_caa74ab91b02ca38fd6cc5a6298035ba.pdf kostenfrei https://doaj.org/toc/2423-4257 Journal toc kostenfrei https://doaj.org/toc/2588-2589 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2 2016 2 98-108 |
allfieldsGer |
10.22080/jgr.2017.12953.1068 doi (DE-627)DOAJ055813569 (DE-599)DOAJ0dc864074bf64c42993fe5f0f7897391 DE-627 ger DE-627 rakwb eng QH426-470 Elham Ghazizadeh verfasserin aut Direct Assay of miR-223, miR-145, and miR-16 by a Novel Method of Mimic PCR in Serum of Breast Cancer Patients 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The role of microRNAs (miRs) is shown as a biomarker whose expression level changes have been associated with cancer development and progression. Circulating miRNAs have been postulated as biomarkers for breast cancer. Detection and diagnosis of miRNA markers could provide an improved and sensitive method in the clinical application. In this study, we applied and improved the effective approach by coupling a deoxyuridine-incorporated RT oligonucleotide with a secondary structure and a mimic PCR for assessment and direct detection of circulating miRs in serum. We designed mut miR-16, mut miR-145, and mut miR-223 as mimic miRs. These mimic miRs were used in RT-PCR for detection and quantification assay. As normalization of these mut miRs was performed with themselves, our mimic construct with 80 bp of these miRs shows the best normalization for this method in blood samples. This assay was tested in serum from 15 patients with different stages of breast cancer and 10 healthy female donors. According to our results, using a combination of miR-16 and miR-145 could represent as one of the best biomarker (p biomarker micro rna mimic pcr breast cancer Genetics Faranak Hadi verfasserin aut Maryam Zare verfasserin aut In Journal of Genetic Resources University of Mazandaran, 2021 2(2016), 2, Seite 98-108 (DE-627)1767903766 25882589 nnns volume:2 year:2016 number:2 pages:98-108 https://doi.org/10.22080/jgr.2017.12953.1068 kostenfrei https://doaj.org/article/0dc864074bf64c42993fe5f0f7897391 kostenfrei http://sc.journals.umz.ac.ir/article_1659_caa74ab91b02ca38fd6cc5a6298035ba.pdf kostenfrei https://doaj.org/toc/2423-4257 Journal toc kostenfrei https://doaj.org/toc/2588-2589 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2 2016 2 98-108 |
allfieldsSound |
10.22080/jgr.2017.12953.1068 doi (DE-627)DOAJ055813569 (DE-599)DOAJ0dc864074bf64c42993fe5f0f7897391 DE-627 ger DE-627 rakwb eng QH426-470 Elham Ghazizadeh verfasserin aut Direct Assay of miR-223, miR-145, and miR-16 by a Novel Method of Mimic PCR in Serum of Breast Cancer Patients 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The role of microRNAs (miRs) is shown as a biomarker whose expression level changes have been associated with cancer development and progression. Circulating miRNAs have been postulated as biomarkers for breast cancer. Detection and diagnosis of miRNA markers could provide an improved and sensitive method in the clinical application. In this study, we applied and improved the effective approach by coupling a deoxyuridine-incorporated RT oligonucleotide with a secondary structure and a mimic PCR for assessment and direct detection of circulating miRs in serum. We designed mut miR-16, mut miR-145, and mut miR-223 as mimic miRs. These mimic miRs were used in RT-PCR for detection and quantification assay. As normalization of these mut miRs was performed with themselves, our mimic construct with 80 bp of these miRs shows the best normalization for this method in blood samples. This assay was tested in serum from 15 patients with different stages of breast cancer and 10 healthy female donors. According to our results, using a combination of miR-16 and miR-145 could represent as one of the best biomarker (p biomarker micro rna mimic pcr breast cancer Genetics Faranak Hadi verfasserin aut Maryam Zare verfasserin aut In Journal of Genetic Resources University of Mazandaran, 2021 2(2016), 2, Seite 98-108 (DE-627)1767903766 25882589 nnns volume:2 year:2016 number:2 pages:98-108 https://doi.org/10.22080/jgr.2017.12953.1068 kostenfrei https://doaj.org/article/0dc864074bf64c42993fe5f0f7897391 kostenfrei http://sc.journals.umz.ac.ir/article_1659_caa74ab91b02ca38fd6cc5a6298035ba.pdf kostenfrei https://doaj.org/toc/2423-4257 Journal toc kostenfrei https://doaj.org/toc/2588-2589 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2 2016 2 98-108 |
language |
English |
source |
In Journal of Genetic Resources 2(2016), 2, Seite 98-108 volume:2 year:2016 number:2 pages:98-108 |
sourceStr |
In Journal of Genetic Resources 2(2016), 2, Seite 98-108 volume:2 year:2016 number:2 pages:98-108 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
biomarker micro rna mimic pcr breast cancer Genetics |
isfreeaccess_bool |
true |
container_title |
Journal of Genetic Resources |
authorswithroles_txt_mv |
Elham Ghazizadeh @@aut@@ Faranak Hadi @@aut@@ Maryam Zare @@aut@@ |
publishDateDaySort_date |
2016-01-01T00:00:00Z |
hierarchy_top_id |
1767903766 |
id |
DOAJ055813569 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ055813569</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230308193632.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.22080/jgr.2017.12953.1068</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ055813569</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ0dc864074bf64c42993fe5f0f7897391</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QH426-470</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Elham Ghazizadeh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Direct Assay of miR-223, miR-145, and miR-16 by a Novel Method of Mimic PCR in Serum of Breast Cancer Patients</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The role of microRNAs (miRs) is shown as a biomarker whose expression level changes have been associated with cancer development and progression. Circulating miRNAs have been postulated as biomarkers for breast cancer. Detection and diagnosis of miRNA markers could provide an improved and sensitive method in the clinical application. In this study, we applied and improved the effective approach by coupling a deoxyuridine-incorporated RT oligonucleotide with a secondary structure and a mimic PCR for assessment and direct detection of circulating miRs in serum. We designed mut miR-16, mut miR-145, and mut miR-223 as mimic miRs. These mimic miRs were used in RT-PCR for detection and quantification assay. As normalization of these mut miRs was performed with themselves, our mimic construct with 80 bp of these miRs shows the best normalization for this method in blood samples. This assay was tested in serum from 15 patients with different stages of breast cancer and 10 healthy female donors. According to our results, using a combination of miR-16 and miR-145 could represent as one of the best biomarker (p</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">biomarker</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">micro rna</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">mimic pcr</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">breast cancer</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Genetics</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Faranak Hadi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Maryam Zare</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Journal of Genetic Resources</subfield><subfield code="d">University of Mazandaran, 2021</subfield><subfield code="g">2(2016), 2, Seite 98-108</subfield><subfield code="w">(DE-627)1767903766</subfield><subfield code="x">25882589</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:2</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:98-108</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.22080/jgr.2017.12953.1068</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/0dc864074bf64c42993fe5f0f7897391</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://sc.journals.umz.ac.ir/article_1659_caa74ab91b02ca38fd6cc5a6298035ba.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2423-4257</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2588-2589</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">2</subfield><subfield code="j">2016</subfield><subfield code="e">2</subfield><subfield code="h">98-108</subfield></datafield></record></collection>
|
callnumber-first |
Q - Science |
author |
Elham Ghazizadeh |
spellingShingle |
Elham Ghazizadeh misc QH426-470 misc biomarker misc micro rna misc mimic pcr misc breast cancer misc Genetics Direct Assay of miR-223, miR-145, and miR-16 by a Novel Method of Mimic PCR in Serum of Breast Cancer Patients |
authorStr |
Elham Ghazizadeh |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)1767903766 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
QH426-470 |
illustrated |
Not Illustrated |
issn |
25882589 |
topic_title |
QH426-470 Direct Assay of miR-223, miR-145, and miR-16 by a Novel Method of Mimic PCR in Serum of Breast Cancer Patients biomarker micro rna mimic pcr breast cancer |
topic |
misc QH426-470 misc biomarker misc micro rna misc mimic pcr misc breast cancer misc Genetics |
topic_unstemmed |
misc QH426-470 misc biomarker misc micro rna misc mimic pcr misc breast cancer misc Genetics |
topic_browse |
misc QH426-470 misc biomarker misc micro rna misc mimic pcr misc breast cancer misc Genetics |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Journal of Genetic Resources |
hierarchy_parent_id |
1767903766 |
hierarchy_top_title |
Journal of Genetic Resources |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)1767903766 |
title |
Direct Assay of miR-223, miR-145, and miR-16 by a Novel Method of Mimic PCR in Serum of Breast Cancer Patients |
ctrlnum |
(DE-627)DOAJ055813569 (DE-599)DOAJ0dc864074bf64c42993fe5f0f7897391 |
title_full |
Direct Assay of miR-223, miR-145, and miR-16 by a Novel Method of Mimic PCR in Serum of Breast Cancer Patients |
author_sort |
Elham Ghazizadeh |
journal |
Journal of Genetic Resources |
journalStr |
Journal of Genetic Resources |
callnumber-first-code |
Q |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2016 |
contenttype_str_mv |
txt |
container_start_page |
98 |
author_browse |
Elham Ghazizadeh Faranak Hadi Maryam Zare |
container_volume |
2 |
class |
QH426-470 |
format_se |
Elektronische Aufsätze |
author-letter |
Elham Ghazizadeh |
doi_str_mv |
10.22080/jgr.2017.12953.1068 |
author2-role |
verfasserin |
title_sort |
direct assay of mir-223, mir-145, and mir-16 by a novel method of mimic pcr in serum of breast cancer patients |
callnumber |
QH426-470 |
title_auth |
Direct Assay of miR-223, miR-145, and miR-16 by a Novel Method of Mimic PCR in Serum of Breast Cancer Patients |
abstract |
The role of microRNAs (miRs) is shown as a biomarker whose expression level changes have been associated with cancer development and progression. Circulating miRNAs have been postulated as biomarkers for breast cancer. Detection and diagnosis of miRNA markers could provide an improved and sensitive method in the clinical application. In this study, we applied and improved the effective approach by coupling a deoxyuridine-incorporated RT oligonucleotide with a secondary structure and a mimic PCR for assessment and direct detection of circulating miRs in serum. We designed mut miR-16, mut miR-145, and mut miR-223 as mimic miRs. These mimic miRs were used in RT-PCR for detection and quantification assay. As normalization of these mut miRs was performed with themselves, our mimic construct with 80 bp of these miRs shows the best normalization for this method in blood samples. This assay was tested in serum from 15 patients with different stages of breast cancer and 10 healthy female donors. According to our results, using a combination of miR-16 and miR-145 could represent as one of the best biomarker (p |
abstractGer |
The role of microRNAs (miRs) is shown as a biomarker whose expression level changes have been associated with cancer development and progression. Circulating miRNAs have been postulated as biomarkers for breast cancer. Detection and diagnosis of miRNA markers could provide an improved and sensitive method in the clinical application. In this study, we applied and improved the effective approach by coupling a deoxyuridine-incorporated RT oligonucleotide with a secondary structure and a mimic PCR for assessment and direct detection of circulating miRs in serum. We designed mut miR-16, mut miR-145, and mut miR-223 as mimic miRs. These mimic miRs were used in RT-PCR for detection and quantification assay. As normalization of these mut miRs was performed with themselves, our mimic construct with 80 bp of these miRs shows the best normalization for this method in blood samples. This assay was tested in serum from 15 patients with different stages of breast cancer and 10 healthy female donors. According to our results, using a combination of miR-16 and miR-145 could represent as one of the best biomarker (p |
abstract_unstemmed |
The role of microRNAs (miRs) is shown as a biomarker whose expression level changes have been associated with cancer development and progression. Circulating miRNAs have been postulated as biomarkers for breast cancer. Detection and diagnosis of miRNA markers could provide an improved and sensitive method in the clinical application. In this study, we applied and improved the effective approach by coupling a deoxyuridine-incorporated RT oligonucleotide with a secondary structure and a mimic PCR for assessment and direct detection of circulating miRs in serum. We designed mut miR-16, mut miR-145, and mut miR-223 as mimic miRs. These mimic miRs were used in RT-PCR for detection and quantification assay. As normalization of these mut miRs was performed with themselves, our mimic construct with 80 bp of these miRs shows the best normalization for this method in blood samples. This assay was tested in serum from 15 patients with different stages of breast cancer and 10 healthy female donors. According to our results, using a combination of miR-16 and miR-145 could represent as one of the best biomarker (p |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
2 |
title_short |
Direct Assay of miR-223, miR-145, and miR-16 by a Novel Method of Mimic PCR in Serum of Breast Cancer Patients |
url |
https://doi.org/10.22080/jgr.2017.12953.1068 https://doaj.org/article/0dc864074bf64c42993fe5f0f7897391 http://sc.journals.umz.ac.ir/article_1659_caa74ab91b02ca38fd6cc5a6298035ba.pdf https://doaj.org/toc/2423-4257 https://doaj.org/toc/2588-2589 |
remote_bool |
true |
author2 |
Faranak Hadi Maryam Zare |
author2Str |
Faranak Hadi Maryam Zare |
ppnlink |
1767903766 |
callnumber-subject |
QH - Natural History and Biology |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.22080/jgr.2017.12953.1068 |
callnumber-a |
QH426-470 |
up_date |
2024-07-03T17:10:32.114Z |
_version_ |
1803578645798715392 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ055813569</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230308193632.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.22080/jgr.2017.12953.1068</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ055813569</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ0dc864074bf64c42993fe5f0f7897391</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QH426-470</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Elham Ghazizadeh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Direct Assay of miR-223, miR-145, and miR-16 by a Novel Method of Mimic PCR in Serum of Breast Cancer Patients</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The role of microRNAs (miRs) is shown as a biomarker whose expression level changes have been associated with cancer development and progression. Circulating miRNAs have been postulated as biomarkers for breast cancer. Detection and diagnosis of miRNA markers could provide an improved and sensitive method in the clinical application. In this study, we applied and improved the effective approach by coupling a deoxyuridine-incorporated RT oligonucleotide with a secondary structure and a mimic PCR for assessment and direct detection of circulating miRs in serum. We designed mut miR-16, mut miR-145, and mut miR-223 as mimic miRs. These mimic miRs were used in RT-PCR for detection and quantification assay. As normalization of these mut miRs was performed with themselves, our mimic construct with 80 bp of these miRs shows the best normalization for this method in blood samples. This assay was tested in serum from 15 patients with different stages of breast cancer and 10 healthy female donors. According to our results, using a combination of miR-16 and miR-145 could represent as one of the best biomarker (p</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">biomarker</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">micro rna</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">mimic pcr</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">breast cancer</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Genetics</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Faranak Hadi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Maryam Zare</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Journal of Genetic Resources</subfield><subfield code="d">University of Mazandaran, 2021</subfield><subfield code="g">2(2016), 2, Seite 98-108</subfield><subfield code="w">(DE-627)1767903766</subfield><subfield code="x">25882589</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:2</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:98-108</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.22080/jgr.2017.12953.1068</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/0dc864074bf64c42993fe5f0f7897391</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://sc.journals.umz.ac.ir/article_1659_caa74ab91b02ca38fd6cc5a6298035ba.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2423-4257</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2588-2589</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">2</subfield><subfield code="j">2016</subfield><subfield code="e">2</subfield><subfield code="h">98-108</subfield></datafield></record></collection>
|
score |
7.400275 |